Home › NDC Lookup › RxCUI directory › RxCUI 1673566

Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochl... — RxCUI 1673566

RxNorm drug concept · Semantic branded drug
RxCUI 1673566 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1673566
Official nameBacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment [Cuadriderma]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCuadriderma (bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG) per GM Topical Ointment; Cuadriderma 500 UNT / 3.5 MG / 10,000 UNT / 10 MG per GM Topical Ointment
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bacitracin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a first aid antibiotic you put directly on the skin to help prevent infection in minor cuts, scrapes, and burns. It's not meant for serious or deep wounds — just everyday smal...
  • What exactly is bacitracin topical used for?
  • Use a small amount — about the size of the tip of your finger — and apply it to the clean, dry area 1 to 3 times a day. You can put a sterile bandage over it if you like. Don't use...
  • Not without checking with your doctor first. Bacitracin topical is meant for minor wounds. Deep or puncture wounds, animal bites, and serious burns need a doctor's evaluation — thi...
📖 Read our full Bacitracin Topical guide →

🕸️ Concept Web — How Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG /... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment [Cuadriderma] RxCUI 1673566

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Bacitracin 1291
    • Neomycin 7299
    • Polymyxin B 8536
    • Pramoxine 34347
    • Bacitracin / neomycin / polymyxin B / pramoxine 466540
    • Pramoxine hydrochloride 57555
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cuadriderma 1673562
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment 374798
    • Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Ointment 2645927
    • Bacitracin / neomycin / polymyxin B / pramoxine Topical Product 1155349
    • Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Product 2662300
    • Bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment [Cuadriderma] 1673564
    • Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Ointment [Cuadriderma] 2654222
    • Cuadriderma Topical Product 1673565
    • Topical Ointment 316985
    • +1 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 21 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment SCD · 1359350
  • Bacitracin 0.5 UNT/MG SCDC · 315454
  • Neomycin 0.0035 MG/MG SCDC · 328185
  • Polymyxin B 10 UNT/MG SCDC · 328475
  • Pramoxine hydrochloride 0.01 MG/MG SCDC · 995190
  • Bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment SCDF · 374798
  • Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Ointment SCDFP · 2645927
  • Bacitracin / neomycin / polymyxin B / pramoxine Topical Product SCDG · 1155349
  • Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Product SCDGP · 2662300

Brand-Name Concepts

  • Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG [Cuadriderma] SBDC · 1673563
  • Bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment [Cuadriderma] SBDF · 1673564
  • Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Ointment [Cuadriderma] SBDFP · 2654222
  • Cuadriderma Topical Product SBDG · 1673565
  • Cuadriderma BN · 1673562

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1673566 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58988-1170-01 1 TUBE in 1 CARTON (58988-1170-1) / 28.35 g in 1 TUBE Cuadriderma ProMex LLC 2013-05-31
Observed labelers: ProMex LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.